1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Kawasaki Disease Global Clinical Trials Review, H2, 2014

Kawasaki Disease Global Clinical Trials Review, H2, 2014

  • October 2014
  • -
  • Global Data
  • -
  • 67 pages

Kawasaki Disease Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Kawasaki Disease Global Clinical Trials Review, H2, 2014" provides data on the Kawasaki Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kawasaki Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Kawasaki Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Kawasaki Disease Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Kawasaki Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Kawasaki Disease to Immunology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Kawasaki Disease to Immunology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Kawasaki Disease 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Kawasaki Disease Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Bristol-Myers Squibb Company 31
Clinical Trial Overview of Bristol-Myers Squibb Company 31
Mitsubishi Chemical Holdings Corporation 32
Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation 32
Hawaii Pacific Health 33
Clinical Trial Overview of Hawaii Pacific Health 33
Green Cross Holdings Corporation 34
Clinical Trial Overview of Green Cross Holdings Corporation 34
Bio Products Laboratory Ltd. 35
Clinical Trial Overview of Bio Products Laboratory Ltd. 35
Baxter International Inc. 36
Clinical Trial Overview of Baxter International Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
University of California, San Diego 37
Clinical Trial Overview of University of California, San Diego 37
Tokyo Metropolitan Children's Medical Center 38
Clinical Trial Overview of Tokyo Metropolitan Children's Medical Center 38
National Heart, Lung, and Blood Institute 39
Clinical Trial Overview of National Heart, Lung, and Blood Institute 39
Toho University 40
Clinical Trial Overview of Toho University 40
Saitama Medical University 41
Clinical Trial Overview of Saitama Medical University 41
Jichi Medical University 42
Clinical Trial Overview of Jichi Medical University 42
Pontificia Universidad Catolica de Chile 43
Clinical Trial Overview of Pontificia Universidad Catolica de Chile 43
University of Leeds 44
Clinical Trial Overview of University of Leeds 44
Nihon University 45
Clinical Trial Overview of Nihon University 45
University of Nebraska 46
Clinical Trial Overview of University of Nebraska 46
Five Key Clinical Profiles 47
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67

List of Tables

Kawasaki Disease Therapeutics, Global, Clinical Trials by Region, 2014* 7
Kawasaki Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Kawasaki Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Kawasaki Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Kawasaki Disease Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Kawasaki Disease Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Kawasaki Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Kawasaki Disease to Immunology Clinical Trials, G7 Countries (%), 2014* 14
Kawasaki Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Kawasaki Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Kawasaki Disease to Immunology Clinical Trials, E7 Countries (%), 2014* 17
Kawasaki Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Kawasaki Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Kawasaki Disease Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Kawasaki Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Kawasaki Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Kawasaki Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Kawasaki Disease Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Kawasaki Disease Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Kawasaki Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Kawasaki Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Kawasaki Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Kawasaki Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Kawasaki Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 31
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Chemical Holdings Corporation, 2014* 32
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hawaii Pacific Health, 2014* 33
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Holdings Corporation, 2014* 34
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio Products Laboratory Ltd., 2014* 35
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 36
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 37
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Metropolitan Children's Medical Center, 2014* 38
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 39
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Toho University, 2014* 40
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 41
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Jichi Medical University, 2014* 42
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pontificia Universidad Catolica de Chile, 2014* 43
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leeds, 2014* 44
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2014* 45
Kawasaki Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014* 46

List of Figures

Kawasaki Disease Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Kawasaki Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Kawasaki Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Kawasaki Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Kawasaki Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Kawasaki Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Kawasaki Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Kawasaki Disease to Immunology Clinical Trials, G7 Countries (%), 2014* 14
Kawasaki Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Kawasaki Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Kawasaki Disease to Immunology Clinical Trials, E7 Countries (%), 2014* 17
Kawasaki Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Kawasaki Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Kawasaki Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Kawasaki Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Kawasaki Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Kawasaki Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Kawasaki Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Kawasaki Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Kawasaki Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Kawasaki Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Kawasaki Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 66

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.